GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » Change In Receivables

Celestial Biolabs (BOM:532871) Change In Receivables : ₹0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs Change In Receivables?

Celestial Biolabs's change in receivables for the quarter that ended in Dec. 2023 was ₹0.00 Mil. It means Celestial Biolabs's Accounts Receivable stayed the same from Mar. 2023 to Dec. 2023 .

Celestial Biolabs's change in receivables for the fiscal year that ended in Mar. 2023 was ₹1.25 Mil. It means Celestial Biolabs's Accounts Receivable declined by ₹1.25 Mil from Mar. 2022 to Mar. 2023 .

Celestial Biolabs's Accounts Receivable for the quarter that ended in Dec. 2023 was ₹0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Celestial Biolabs's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Celestial Biolabs's liquidation value for the three months ended in Dec. 2023 was ₹0.00 Mil.


Celestial Biolabs Change In Receivables Historical Data

The historical data trend for Celestial Biolabs's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs Change In Receivables Chart

Celestial Biolabs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.33 118.08 0.48 -0.53 1.25

Celestial Biolabs Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Celestial Biolabs Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celestial Biolabs  (BOM:532871) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Celestial Biolabs's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.368*91
=0.00

2. In Ben Graham's calculation of liquidation value, Celestial Biolabs's accounts receivable are only considered to be worth 75% of book value:

Celestial Biolabs's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-0+0.75 * 0+0.5 * 0
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celestial Biolabs Change In Receivables Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Celestial Biolabs (BOM:532871) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076
Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines